What is NPH?
NPH is a disorder that continues to intrigue medical researchers, clinicians, and concerned families. It is an uncommon cause of dementia, but early treatment can make a difference, so it is important to recognize it at the earliest stage possible. In NPH, the ventricles (the inner, fluid-filled chambers of the brain) enlarge as though expanded by fluid pressure. Unexpectedly, when tested with a lumbar puncture (“spinal tap”), the pressure of the cerebrospinal fluid (CSF) which fills those chambers seems to be normal, accounting for this condition’s name. NPH that has no apparent medical cause, called iNPH or idiopathic NPH, is different from secondary NPH (sNPH), which is caused by diseases or injuries that interfere with CSF absorption and may be associated with moderate elevation of CSF pressure despite the “normal pressure” name. Although iNPH accounts for fewer than one in 15 cases of dementia, early detection can point the way toward specific and helpful treatment.
iNPH is often found alongside disorders that might stress the blood supply to the brain tissue around the brain’s ventricles: high blood pressure, diabetes, and lipid disorders. It is possible that brain tissue destruction related to impaired blood supply plays a role in the disease’s development. iNPH can become symptomatic as early as a person’s 50s or 60s.
How is NPH Diagnosed?
The diagnosis of NPH is prompted when a patient describes or shows a characteristic group of three symptoms: gait disorder, dementia, and incontinence. The absence of one or more of these symptoms does not make the diagnosis impossible, though, and some people with all these symptoms have no evidence of NPH. Once there is clinical suspicion of NPH, neuroimaging with a CT or MRI is needed for further assessment. The presence of characteristically large ventricles on brain imaging leads to a referral for a clinical diagnostic test called the “large volume CSF tap.” In this type of lumbar puncture, the removal of 40 to 50 ml (milliliters) of CSF can lead to significant and rapid clinical improvement and some investigators consider this to be a predictor of better treatment response. Other tests, such as those that use different imaging methods or evaluate CSF flow, may be useful but are not used routinely. These include a special PET scan to assess regional brain metabolic activity and SPECT scanning to evaluate blood flow in the brain.
Symptoms of NPH
Difficulty walking is the most frequent problem: balance is impaired, turning becomes more difficult, and the legs may show muscular rigidity and exaggerated deep tendon reflexes. Dementia is the next most common problem in iNPH, and often includes executive function difficulties (the ability to reason and solve problems.) and apathy. Memory, attention, visuospatial functions (the ability to understand such things as shapes, locations, and directions), and mood can also be affected. Urinary incontinence, the third characteristic symptom, affects about half of people with iNPH.
Treatments for NPH
The NPH treatment considered most definitive is ventriculoperitoneal shunting, which requires surgical insertion of a tube that runs from the brain, inside the neck, past the chest cavity, and into the abdominal cavity where excess cerebrospinal fluid is deposited. When the NPH is secondary to disorders that limit CSF absorption, the justification for this surgical treatment is clear—but shunting also helps some patients with iNPH. Shunting of NPH significantly helps about one-third of those who have the procedure done.
Complications are not unusual and they can include serious problems such as stroke, bleeding or infection in the brain, and permanent neurological deficits or death. When dementia is the main or only symptom, the likelihood of improvement with shunting is limited. Improvement in gait problems and incontinence are more likely. Sometimes improvement after this procedure is only temporary, though others can continue to improve for up to two years. Shunting at an earlier stage of the illness, before three years, is considered more likely to be helpful.
- Alzheimer’s Disease Toolkit (Helpful Information to Understand and Manage Alzheimer's Disease)
- Expert Information on Alzheimer's Disease (Articles)
- What is Dementia (Article)
- What is the Difference Between Dementia & Alzheimer’s Disease (Article)
- Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: A systematic review of diagnosis and outcome. Neurosurgery 2001;49:1166-86.
- Picascia M, Minafra B, Zangaglia R, et al. Spectrum of cognitive disorders in idiopathic normal pressure hydrocephalus. Functional Neurology 2016;31:143-7.
- Picascia M, Zangaglia R, Bernini S, et al. A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus. Functional Neurology 2015;30:217-228.
- Koivisto AM, Alafuzoff I, Savolainen S, et al. Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 2013;72:1-8.
This content was last updated on: November 10, 2020
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.